Q3-FY26 · Amit Bakshi
We retain our position that we expect to be among the first launches in India post LOE.
ERISLIFESCIENCES / language trends
Read confidence between the lines.
Eris Lifesciences · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q3-FY26 · Amit Bakshi
The only problem which we see in the export business injectable is a little bit of a capacity problem and this would remain for at least one and a half years.
Q3-FY26 · V. Krishna Kumar
Our DBF aggregate margins are at 37%. So I would say that is the kind of aspiration we would have at the very least.